InvestSMART

ReNerve Limited (ASX: RNV) - Announcements

- Current share price for RNV : $0.089

ASX company news and announcements for ReNerve Limited (RNV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ReNerve Limited (RNV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ReNerve Limited (RNV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ReNerve Limited (RNV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 ReNerve - Appendix 4E 28 Aug 2026 9:35AM $0.073 $0.089 risen by 21.92%
$12 Cleansing Notice 25 Aug 2026 12:59PM $0.077 $0.089 risen by 15.58%
$12 Application for quotation of securities - RNV 25 Aug 2026 12:54PM $0.077 $0.089 risen by 15.58%
$12 Proposed issue of securities - RNV 25 Aug 2026 9:09AM $0.077 $0.089 risen by 15.58%
$12 Quarterly Investor Presentation 19 Aug 2026 10:38AM $0.077 $0.089 risen by 15.58%
$12 Quarterly Investor Webinar 12 Aug 2026 10:16AM $0.075 $0.089 risen by 18.67%
$12 ReNerve Secures Marketing Approval in India 10 Aug 2026 10:44AM $0.074 $0.089 risen by 20.27%
$12 ReNerve Secures Marketing Approval in the Philippines 6 Aug 2026 10:06AM $0.080 $0.089 risen by 11.25%
$12 Change of Director's Interest Notice - J Chick 3 Aug 2026 11:17AM $0.085 $0.089 risen by 4.71%
$12 Q4 FY26 Activities Report and Appendix 4C 29 Jul 2026 9:24AM $0.077 $0.089 risen by 15.58%
$12 Notification regarding unquoted securities - RNV 13 Jul 2026 2:01PM $0.080 $0.089 risen by 11.25%
$12 Proposed issue of securities - RNV 9 Jul 2026 9:14AM $0.079 $0.089 risen by 12.66%
$12 ReNerve Secures up to A$5 Million Funding Facility 9 Jul 2026 9:05AM $0.079 $0.089 risen by 12.66%
$12 ReNerve Secures Marketing Approval in Indonesia 6 Jul 2026 10:11AM $0.080 $0.089 risen by 11.25%
$12 Notification of cessation of securities - RNV 16 Jun 2026 9:02AM $0.084 $0.089 risen by 5.95%
$12 Clarification of Key Terms STC Distribution Agreement 16 Jun 2026 9:01AM $0.084 $0.089 risen by 5.95%
$12 ReNerve appoints J4 as second Empliq manufacturing partner 11 Jun 2026 9:47AM $0.077 $0.089 risen by 15.58%
$12 ReNerve appoints distribution partner for Malaysian Market 5 Jun 2026 9:15AM $0.077 $0.089 risen by 15.58%
$12 New distribution agreement for broader Hong Kong market 1 Jun 2026 9:44AM $0.080 $0.089 risen by 11.25%
$12 Quarterly Investor Presentation 8 May 2026 10:02AM $0.088 $0.089 risen by 1.14%
$12 Quarterly Investor Webinar 1 May 2026 11:00AM $0.105 $0.089 fallen by 15.24%
$12 Notification of cessation of securities - RNV 1 May 2026 9:11AM $0.105 $0.089 fallen by 15.24%
$12 Final Director's Interest Notice - D Rhodes 30 Apr 2026 9:53AM $0.110 $0.089 fallen by 19.09%
$12 Q3 FY26 Activities Report and Appendix 4C 30 Apr 2026 9:50AM $0.110 $0.089 fallen by 19.09%
$12 Nerve Guide Matrix Enters Stage 3 of Commercial Development 15 Apr 2026 9:45AM $0.100 $0.089 fallen by 11%

26 - 50 of 179 results

Page 2 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.